1. 1073PSurvival benefit of adjuvant chemotherapy vs active surveillance in locally advanced nasopharyngeal carcinoma: A multicenter retrospective study. (23rd October 2018) Authors: Danchaivijitr, P; Dechaphunkul, A; Paoin, C; Setakornnukul, J; Dechaphunkul, T; Jiratrachu, R; Niyomnaitham, S; Suktitipat, B; Sookthon, C; Pattaranutaporn, P; Jiarpinitnun, C; Ngamphaiboon, N Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1076PComparison of 3-weekly cisplatin versus 3-weekly carboplatin in patients with locally advanced nasopharyngeal carcinoma (LA-NPC) receiving concurrent chemoradiotherapy (CCRT): A multicenter retrospective study. (23rd October 2018) Authors: Dechaphunkul, A; Danchaivijitr, P; Jiratrachu, R; Dechaphunkul, T; Sookthon, C; Jiarpinitnun, C; Paoin, C; Setakornnukul, J; Niyomnaitham, S; Suktitipat, B; Pattaranutaporn, P; Ngamphaiboon, N Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1090PFrequency of PIK3CA mutations in head and neck squamous cell carcinoma (HNSCC) in southern Thailand. (23rd October 2018) Authors: Thongwatchara, P; Thongsuksai, P; Dechaphunkul, T; Dechaphunkul, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 150PA Phase Ib Study of IMU-131 HER2/neu peptide vaccine plus chemotherapy in patients with HER2/neu overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction. (24th November 2019) Authors: Chao, Y; Maglakelidze, M; Bulat, L V; Yau, T; Tanasanvimon, S; Charoentum, C; Arpornwirat, W; Maneechavakajorn, J; Dechaphunkul, A; Ungtrakul, T; Yen, C-J; Bai, L-Y; Chou, W-C; Weidermann, U; Garner-Spitzer, E; Ede, N; Chong, L; Good, A Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 308PProphylactic percutaneous endoscopic gastrostomy in patients with nasopharyngeal carcinoma receiving concurrent chemoradiotherapy. (25th November 2018) Authors: Dechaphunkul, T; Ngamphaiboon, N; Danchaivijitr, P; Jiratrachu, R; Dechaphunkul, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 428PEfficacy of single dose NEPA, a fixed combination of netupitant and palonosetron, versus a 3-day regimen of aprepitant/granisetron (APR/GRAN) for prevention of nausea in patients receiving high dose cisplatin. (25th November 2018) Authors: Dechaphunkul, A; Lu, S; Olivari, S; Zhang, L Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 489OOsimertinib vs standard of care (SoC) EGFR-TKI as first-line therapy in patients (pts) with untreated EGFRm advanced NSCLC: FLAURA post-progression outcomes. (25th November 2018) Authors: Planchard, D; Boyer, M; Lee, J-S; Dechaphunkul, A; Cheema, P; Takahashi, T; Todd, A; McKeown, A; Rukazenkov, Y; Ohe, Y Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC). (28th October 2017) Authors: Zhang, L; Lu, S; Feng, J; Dechaphunkul, A; Chang, J; Wang, D; Chessari, S; Lanzarotti, C; Jordan, K; Aapro, M Journal: Annals of oncology Issue: Volume 29:Number 2(2018) Page Start: 452 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Afatinib versus methotrexate as second-line treatment in Asian patients with recurrent or metastatic squamous cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 3): an open-label, randomised phase III trial. (10th September 2019) Authors: Guo, Y; Ahn, M -J; Chan, A; Wang, C -H; Kang, J -H; Kim, S -B; Bello, M; Arora, R S; Zhang, Q; He, X; Li, P; Dechaphunkul, A; Kumar, V; Kamble, K; Li, W; Kandil, A; Cohen, E E W; Geng, Y; Zografos, E; Tang, P Z Journal: Annals of oncology Issue: Volume 30:Number 11(2019) Page Start: 1831 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. CN10Cancer care through the fire and flames: 3-year experience in the utilisation of electronic consultation and referral system at the red zone in Southern Thailand. (1st October 2019) Authors: Rattanakhot, N; Dechaphunkul, A; Sunpaweravong, P; Sathitruangsak, C; Maisrikrod, A; Songserm, M; Jiratrachu, R; Sangthawan, D; Peerawong, T; Phungrassami, T; Rordlamool, P; Sakdejayont, S Journal: Annals of oncology Issue: Volume 30(2019)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗